CORMEDIX INC. - COMMON STOCK
9.3800
02-May-25 15:45:00
15 minutes delayed
Stocks
-0.2700
-2.80%
Today's range
9.2500 - 9.8200
ISIN
N/A
Source
NASDAQ
-
Cormedix Inc. Announces Resubmission of New Drug Application for DefenCath
28 Feb 2022 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix to Participate in Upcoming January Conferences
04 Jan 2022 07:00:02 By Nasdaq GlobeNewswire
-
CorMedix Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
09 Nov 2021 15:05:02 By Nasdaq GlobeNewswire
-
02 Nov 2021 07:30:01 By Nasdaq GlobeNewswire
-
20 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Executive Leadership Changes
04 Oct 2021 15:01:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Regulatory Update
07 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
12 Aug 2021 15:01:00 By Nasdaq GlobeNewswire
-
28 Jul 2021 07:30:00 By Nasdaq GlobeNewswire
-
10 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference
09 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference
27 May 2021 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Reports First Quarter 2021 Financial Results and Provides Business Update
13 May 2021 15:01:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Appointment of Chief Commercial Officer
13 May 2021 07:30:00 By Nasdaq GlobeNewswire
-
05 May 2021 07:00:02 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Participate at the 7th Annual Truist Securities Life Sciences Summit
28 Apr 2021 07:30:00 By Nasdaq GlobeNewswire
-
CorMedix Has Meeting With FDA on DefenCath Catheter Lock Solution NDA
14 Apr 2021 08:00:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference
07 Apr 2021 07:30:00 By Nasdaq GlobeNewswire
-
30 Mar 2021 15:05:00 By Nasdaq GlobeNewswire
-
23 Mar 2021 07:30:00 By Nasdaq GlobeNewswire